Viridian Therapeutics Inc. Watch

from 10-Q 42 pages [***] = Identified Information Has Been Excluded From This Exhibit Because It Is Both (I) Information That the Company Customarily and Actually Treats as Private or Confidential and (II) Is Not Material. Amended and Restated License Agreement

from 10-Q 12 pages Fifth Amendment to Lease

from 10-Q 11 pages Fourth Amendment to Lease

from 8-K 22 pages Viridian Therapeutics, Inc. Amended & Restated 2016 Equity Incentive Plan Adopted by the Board of Directors: April 19, 2024 Approved by the Stockholders: June 17, 2024

from 10-K 11 pages Viridian Therapeutics, Inc. 2016 Amended and Restated Employee Stock Purchase Plan Adopted by the Board of Directors: November 30, 2016 Approved by the Stockholders: February 10, 2017 Amended and Restated by the Board of Directors: March 30, 2023

from 10-K 6 pages Viridian Therapeutics, Inc. (The “Company”), Pursuant to Its 2016 Amended and Restated Equity Incentive Plan (The “Plan”), Hereby Awards to Participant the Number of Restricted Stock Units Set Forth Below (“Award”). This Award Is Subject to All of the Terms and Conditions as Set Forth Herein and in the Restricted Stock Unit Agreement and the Plan, All of Which Are Attached Hereto and Incorporated Herein in Their Entirety. Capitalized Terms Not Otherwise Defined Herein Shall Have the Meanings Set Forth in the Plan or the Restricted Stock Unit Agreement. in the Event of Any Conflict Between the Terms in the Award and the Plan, the Terms of the Plan Shall Control. Participant: Date of Grant: Vesting Commencement Date: Number of Restricted Stock Units: Consideration: Participant’s Services Vesting Schedule

from 10-K 8 pages Viridian Therapeutics, Inc. Amended and Restated 2016 Equity Incentive Plan Stock Option Grant Notice

from 10-K 11 pages Viridian Therapeutics, Inc. Employment Agreement

from 10-K 2 pages Amendment to Employment Agreement

from 10-K 11 pages Viridian Therapeutics, Inc. Employment Agreement

from 10-K 10 pages Viridian Therapeutics, Inc. Employment Agreement

from 10-K 11 pages Viridian Therapeutics, Inc. Employment Agreement

from 10-K 13 pages Indemnity Agreement

from S-3ASR 34 pages Form of Securities Purchase Agreement

from 10-Q 12 pages Viridian Therapeutics, Inc. Employment Agreement

from 10-Q 12 pages Viridian Therapeutics, Inc. Employment Agreement

from 8-K 34 pages Registration Rights Agreement

from 8-K 53 pages Securities Purchase Agreement

from 8-K 18 pages Viridian Therapeutics, Inc. Amended & Restated 2016 Equity Incentive Plan Adopted by the Board of Directors: April 10, 2023 Approved by the Stockholders: June 14, 2023

from 8-K 11 pages General Release and Separation and Consulting Agreement